{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:27:53Z","timestamp":1781670473177,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.07.043","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:24:16Z","timestamp":1661239456000},"page":"5641-5650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate"],"prefix":"10.1016","volume":"40","author":[{"given":"Raphael","family":"Esson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Rodrigues De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Benair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Devard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Falque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Chareyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Marmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Girerd-Chambaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Logvinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Erika","family":"Navarro Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.07.043_b0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2022.07.043_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: current epidemiology and vaccination strategies","volume":"6","author":"Chen","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.vaccine.2022.07.043_b0015","unstructured":"World Health Organization. Background Paper on Yellow Fever Vaccine. Background Paper on Yellow Fever Vaccine. https:\/\/www.who.int\/immunization\/sage\/meetings\/2013\/april\/1_Background_Paper_Yellow_Fever_Vaccines.pdf; 2013 [accessed May 20, 2020]."},{"key":"10.1016\/j.vaccine.2022.07.043_b0020","unstructured":"World Health Organization. New yellow fever vaccination requirements for travellers. www.who.int\/ith\/updates\/20160727\/en\/; 2016 [accessed May 20, 2020]."},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.043_b0025","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","article-title":"Current status and future prospects of yellow fever vaccines","volume":"14","author":"Beck","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.07.043_b0030","unstructured":"UNICEF. Yellow Fever Vaccine: Current Supply Outlook. https:\/\/www.unicef.org\/supply\/files\/YF_number_3_Supply_Update.pdf; 2016 [accessed Februrary 3, 2020]."},{"key":"10.1016\/j.vaccine.2022.07.043_b0035","unstructured":"Global Alliance for Vaccines and Immunisation. Yellow fever supply and procurement roadmap. https:\/\/www.gavi.org\/sites\/default\/files\/document\/yellow-fever-roadmap-public-summarypdf.pdf; 2017 [accessed May 20, 2020]."},{"issue":"9","key":"10.1016\/j.vaccine.2022.07.043_b0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/M17-1337","article-title":"Yellow Fever Vaccine Shortages in the United States and Abroad: A Critical Issue","volume":"167","author":"Lucey","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2022.07.043_b0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2016.04.025","article-title":"Yellow fever cases in Asia: primed for an epidemic","volume":"48","author":"Wasserman","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.043_b0050","unstructured":"World Health Organization. Globa strategy to eliminate yellow fever epidemics (EYE). https:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/october\/2_EYE_Strategy.pdf; 2016 [accessed May 21, 2020])."},{"key":"10.1016\/j.vaccine.2022.07.043_b0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejpb.2019.07.008","article-title":"A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate","volume":"142","author":"Cl\u00e9net","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2022.07.043_b0060","unstructured":"WIPO IP Portal. WO2019192997 - Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition comprising the same field of the intervention. https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf;jsessionid=1FFE1121CFD5781B621877B72FEC0DA9wapp1nC?docId=WO2019192997&tab=PCTDESCRIPTION; 2019 [accessed Februrary 5, 2020]."},{"issue":"13","key":"10.1016\/j.vaccine.2022.07.043_b0065","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2021.02.033","article-title":"Next generation live-attenuated Yellow Fever vaccine candidate: safety and immuno-efficacy in small animal models","volume":"39","author":"Piras-Douce","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.043_b0070","unstructured":"World Health Organization. Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines. WHO Technical Report Series No. 978. Replacement of Annex 2 of WHO Technical Report Series, No. 872 and of the Amendment to that annex in WHO Technical Report Series, No. 964 (2012). https:\/\/www.who.int\/biologicals\/areas\/vaccines\/TRS_978_Annex_5pdf?ua=1; 2013 [accessed June 25, 2020)."},{"key":"10.1016\/j.vaccine.2022.07.043_b0075","unstructured":"Food and Drug Adminsitration. Guidance for Industry. Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. https:\/\/www.fda.gov\/media\/78428\/download; 2010 [accessed June 25, 2020)."},{"key":"10.1016\/j.vaccine.2022.07.043_b0080","unstructured":"World Health Organization. Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated). Replacement of Annex 1 of WHO Technical Report Series, No. 932. WHO Technical Report Series No. 979. Available at: https:\/\/www.who.int\/biologicals\/areas\/vaccines\/TRS_979_Annex_2pdf?ua=1; 2013 [accessed June 25, 2020]."},{"key":"10.1016\/j.vaccine.2022.07.043_b0085","unstructured":"World Health Organization. WHO Expert Committee on Biological Standardization. WHO Technical Report Series, No. 980. Available at: https:\/\/www.who.int\/biologicals\/WHO_TRS_980_WEBpdf?ua=1; 2014 [accessed June 25, 2020]."},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.043_b0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/infdis\/jit546","article-title":"Comparison of the live attenuated yellow fever vaccine 17D\u2013204 strain to its virulent parental strain Asibi by deep sequencing","volume":"209","author":"Beck","year":"2014","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2022.07.043_b0095","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2022.07.043_b0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"MUSCLE: a multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinf"},{"issue":"22","key":"10.1016\/j.vaccine.2022.07.043_b0105","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks","volume":"89","author":"Henikoff","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.043_b0110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nsb990","article-title":"Visualization of membrane protein domains by cryo-electron microscopy of dengue virus","volume":"10","author":"Zhang","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.043_b0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jviromet.2011.02.013","article-title":"Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology","volume":"173","author":"Fang","year":"2011","journal-title":"J Virol Methods"},{"issue":"15","key":"10.1016\/j.vaccine.2022.07.043_b0120","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D\u2013204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.043_b0125","doi-asserted-by":"crossref","unstructured":"Staples JE, Monath TP, Gershman MD, Barrett ADT. YellowFever Vaccines. In: Plotkins SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin's Vaccines (Seventh Edition): Elsevier; 2018. p. 1181-265.","DOI":"10.1016\/B978-0-323-35761-6.00063-8"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.043_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D\u2013213","volume":"35","author":"Duarte dos Santos","year":"1995","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.043_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/srep26100","article-title":"Molecular determinants of plaque size as an indicator of dengue virus attenuation","volume":"6","author":"Goh","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.07.043_b0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","volume":"479-480","author":"Minor","year":"2015","journal-title":"Virology"},{"issue":"49","key":"10.1016\/j.vaccine.2022.07.043_b0145","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1016\/j.vaccine.2014.05.003","article-title":"Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil","volume":"32","author":"Martins","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.043_b0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"Jennings","year":"1994","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2022.07.043_b0155","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.043_b0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2022.07.043_b0165","article-title":"A risk-based approach to establishing animal-component\u2013free facilities. BioProcess","author":"Pamukcoglu","year":"2009","journal-title":"International"},{"key":"10.1016\/j.vaccine.2022.07.043_b0170","unstructured":"European Commission. Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA\/410\/01 rev.3). Official Journal of the European Union 2011."},{"key":"10.1016\/j.vaccine.2022.07.043_b0175","unstructured":"World Health Organization. WHO guidelines on transmissible spongiform encephalopathies in relation to biological and pharmaceutical products. Available at: https:\/\/www.who.int\/biologicals\/vaccines\/transmissible_spongioform_encephalopathies\/en\/; 2003 [accessed June 3, 2020]."},{"key":"10.1016\/j.vaccine.2022.07.043_b0180","unstructured":"European Pharmacopoeia. General Chapter 5.2.12. Raw materials of biological origin for the production of cell-based and gene therapy medicinal products. 2017."},{"key":"10.1016\/j.vaccine.2022.07.043_b0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-A resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat Struct Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:49Z","timestamp":1759403689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22009392"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}